Talk:ApiJect Systems
This article has not yet been rated on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | |||||||||||
|
Edit Request
[edit]This edit request by an editor with a conflict of interest has now been answered. |
Hi Wikipedia, I am an employee of ApiJect Systems and wanted to request some additions be made to the History section of this article, since it hasn’t been updated in a while. I am requesting the following lines be added to the end of the section:
- In December 2021, ApiJect and Fareva announced a licensing agreement to establish three Blow-Fill-Seal manufacturing lines in France. (Sources: https://www.medicaldesignandoutsourcing.com/fareva-apiject-ink-10-year-licensing-agreement-on-fill-finish-production-lines/ and
https://www.pharmtech.com/view/considering-blow-fill-seal-for-biologic-drugs)
- In April 2022, ApiJect opened the ApiJect Technology Development Center in Florida to work with pharmaceutical companies on its prefilled injectors, with research and development investment from the U.S. Office of the Assistant Secretary for Preparedness and Response and the U.S. Department of Defense. (Sources: https://floridapolitics.com/archives/516594-apiject-systems-opens-technology-development-center-in-orlando/ and https://homelandprepnews.com/stories/76769-aspr-celebrates-construction-of-new-research-and-development-facility-for-production-of-prefilled-injectors/)
- In May 2022, ApiJect raised $111 million from Royalty Pharmaceuticals and Jefferies Financial Group, valuing ApiJect at approximately $300 million. (Sources: https://www.fiercepharma.com/manufacturing/apiject-reels-111m-private-investment-round and https://www.drugdeliverybusiness.com/apiject-picks-up-111m-investment-from-royalty-pharma-jefferies/) Please hyperlink to Jefferies Wiki page.
Thanks in advance for any help here! - Ewapi (talk) 18:02, 29 July 2022 (UTC)
- Hi Ewapi - Confirming these have been implemented with some slight tweaks. Thanks. - Cmccarthy215 (talk) 03:41, 5 August 2022 (UTC)
Edit Request May 16 2022
[edit]This edit request by an editor with a conflict of interest was declined. |
Hi Wikipedia, I am an employee of ApiJect Systems. Since I have a COI, I was hoping someone could help make some updates to the lede and infobox as follows:
Can we expand the first sentence of the lede to read “ApiJect Systems Corporation is an American company founded in 2018 by Marc Koska and based in Stamford, Connecticut that produces pre-filled single use plastic injectors using Blow-Fill-Seal (BFS) manufacturing technology.” (Source for new part: https://www.contractpharma.com/contents/view_breaking-news/2022-04-13/apiject-opens-technology-development-center/)
After the first sentence, can we add “ApiJect works with pharmaceutical and biotech companies to fill their injectable drug products into single-dose prefilled injectors, allowing medicines and vaccines to be filled and delivered to patients.” (Sources: https://www.contractpharma.com/contents/view_breaking-news/2022-04-13/apiject-opens-technology-development-center/, https://drug-dev.com/special-feature-pfs-parenteral-drug-delivery-self-injection-is-very-much-the-new-normal/)
Infobox updates: Remove Franco Negron, and add CEO to Jay Walker’s title. The source is https://www.contractpharma.com/contents/view_breaking-news/2022-04-13/apiject-opens-technology-development-center/
Tagging Cmccarthy215 since they helped out with this last time. Thanks in advance for any help here. - Ewapi (talk) 19:02, 16 May 2022 (UTC)
- Not done for now: First request is promotional, as "pre-filled single use plastic injectors" is already included. The second request is also promotional; I would be willing to add "ApiJect works with pharmaceutical and biotech companies to fill their injectable drug products into single-dose prefilled injectors" if independent sourcing is provided. Same with the last request. These claims currently rely on press releases. PK650 (talk) 08:22, 17 May 2022 (UTC)
- Hi PK650, thank you for the feedback - I understand where you’re coming from. I am okay with just adding your suggested rewrite of the second request. One of the sources I included in my original request in support of that request is not a press release, but third-party: https://drug-dev.com/special-feature-pfs-parenteral-drug-delivery-self-injection-is-very-much-the-new-normal/ Would that be sufficient?
- There has also been some new coverage that I am hoping will be helpful:
- Thanks again for looking into this. Let me know if you have any additional feedback! - Ewapi (talk) 15:47, 25 May 2022 (UTC)
- Hi @PK650:, I meant to use the replyto template above, but I'll use it here to alert you of my response. Thanks for your help! Ewapi (talk) 18:43, 31 May 2022 (UTC)
Edit Request 2
[edit]This edit request by an editor with a conflict of interest has now been answered. |
Hi again, thank you for the help on my previous request. I’d like to also request the addition of an infobox to this page, with the following content. Most of this is already sourced within the page:
Logo: Can you please upload an image of the ApiJect logo to be used here? I’m not able to since my account hasn’t been confirmed yet. Link to logo: https://www.prnewswire.com/news-releases/apiject-issues-statement-on-nbc-digital-news-story-301274020.html Industry: Medical technology Founded: 2018 Founder: Marc Koska Headquarters: Stamford, Connecticut Key People: Marc Koska (Founder), Franco Negron (CEO) (Source:https://www.contractpharma.com/contents/view_breaking-news/2020-07-27/franco-negron-named-ceo-of-apiject-systems-america/) Products: Pre-filled Injectors Website: Apiject.com
Thanks for any help! - Ewapi (talk) 19:08, 14 July 2021 (UTC)
- Hi Ewapi, me again. I have added the infobox to this page as per your request. I also noticed apiject didn't have any wikidata, so i filled some of that in too. - Cmccarthy215 (talk) 20:41, 16 July 2021 (UTC)
Edit Request 1
[edit]This edit request by an editor with a conflict of interest has now been answered. |
Hello Wikipedia! I am an employee of ApiJect Systems. Since I have a conflict of interest, I was wondering if somebody could help me with some edits to this page. I’d like to build out this page with the addition of the following information. Please let me know if you need clarification on any of these requests, and thanks in advance!
1.I am requesting that the intro paragraph be revised to say: “ApiJect Systems Corporation is an American company founded in 2018 by Marc Koska[1] and based in Stamford, Connecticut[2] that produces pre-filled single use plastic injectors (Source: Https://Www.Fox61.Com/Article/Money/Business/Stamford-company-may-play-critical-role-in-covid-vaccine-delivery/520-6f0d67f3-d843-4947-ac1f-cf0150d87232). The company claimed to have the capacity to manufacture pre-filled COVID-19 vaccine syringes[3][4] by the end of 2020.[5]” Note that no information is being removed, just added to new sections where relevant as I outline below.
2.I’d like to request a new section, called “History,” to include the following information:
- Apiject Systems was founded in 2018 by Marc Koska, who invented the Apiject prefilled injector, a prefilled, single-use plastic injector, as a low cost way to get medicine to poorer countries (Source: Https://Www.Fox61.Com/Article/Money/Business/Stamford-company-may-play-critical-role-in-covid-vaccine-delivery/520-6f0d67f3-d843-4947-ac1f-cf0150d87232). Koska previously invented the self-locking K1 syringe to prevent needle reuse (Source: Https://Www.Mmm-online.Com/Home/Channel/4-innovations-that-found-the-right-time-during-the-pandemic/).
- In 2020, Apiject pivoted in order to meet U.S. demand for COVID-19 vaccinations. In May of 2020, the U.S. Department of Health and Human Services and the Department of Defense signed a $138 million deal with Apiject, called Project Jumpstart, to facilitate the production of 100 million prefilled syringes by the end of 2020 and 500 million in 2021 in the event that a COVID-19 vaccine became available (Source: Https://Www.Nbcnews.Com/News/Us-news/Trump-admin-unveils-plan-ramp-syringe-production-future-covid-19-n1204436).
- In November 2020, Apiject was approved for a $590 million loan from the U.S. International Development Finance Corporation to construct a multi-facility campus (Source: https://www.fiercepharma.com/drug-delivery/apiject-snares-590m-government-loan-for-gigafactory-to-produce-billions-pre-filled). The project broke ground in February 2021 in Durham, North Carolina, and was among the largest projects in the nation to break ground that month (Source: Https://Www.Ncconstructionnews.Com/785-million-apiject-gigafactory-in-durham-among-largest-projects-in-nation-to-start-despite-overall-national-decline-dodge/).The factory is designed to deliver production capacity of up to 2 to 3 billion units annually (Source: Https://Drug-dev.Com/Special-feature-pfs-parenteral-manufacturing-how-covid-19-changed-the-market/). It will be suitable for vaccines requiring standard cold storage, including those in need of ultra-cold storage down to -70 degrees Celsius (Source: https://www.fiercepharma.com/drug-delivery/apiject-snares-590m-government-loan-for-gigafactory-to-produce-billions-pre-filled).
- Move this sentence “As of April 21, 2021 the company has failed to produce any syringes,[12]” here, and continue it with “however it has met its obligations under its federal contracts and loan commitments by lining up a subcontractor that promises to produce the syringes once they obtain FDA approval.” (Source: https://www.nbcnews.com/health/health-care/trump-administration-awarded-firm-1-3-billion-make-covid-vaccine-n1263872).
- After that sentence, move this line “The CEO of the company stated in July 2020: "The fact of this matter is, it would be crazy for people to just rely on us...We should be America’s backup at this point, but probably not its primary.”[11] Followed by “According to the White House 100 Days report of June 2021, Health and Human Services is planning to expand Project Jumpstart to $250 million per month through 2023 (Source: https://www.whitehouse.gov/wp-content/uploads/2021/06/100-day-supply-chain-review-report.pdf).”
3. Lastly, I am requesting a new section called “Product” to include the following:
- ApiJect’s prefilled injector uses Blow-Fill-Seal (BFS) manufacturing technology (Source: Https://Drug-dev.Com/Special-feature-pfs-parenteral-manufacturing-how-covid-19-changed-the-market/), which is recognized as an advanced aseptic liquid packaging process (Source: https://cleanroomtechnology.com/news/article_page/ApiJect_selects_IPS_for_Greenfield_blow-fill-seal_aseptic_manufacturing_campus/175751).
- The prefilled injector is created by screwing the pen needle-style hub onto the top of the BFS container (Source:https://cleanroomtechnology.com/news/article_page/ApiJect_selects_IPS_for_Greenfield_blow-fill-seal_aseptic_manufacturing_campus/175751). BFS process uses pharmaceutical-grade plastic resin to create, fill and seal a strip of 12-to-25 drug containers per production line every three seconds (Source: https://www.fiercepharma.com/drug-delivery/apiject-snares-590m-government-loan-for-gigafactory-to-produce-billions-pre-filled).
Thanks again! - Ewapi (talk) 16:22, 23 June 2021 (UTC)
- Hi Ewapi, I can help with these edits. I'll take a look through and see what's doable, and I'll ping you when I'm finished. Thanks! - Cmccarthy215 (talk) 21:10, 23 June 2021 (UTC)
- Hi again Ewapi - These edits have been made.
Proposed edits to page on June 13, 2022
[edit]This edit request by an editor with a conflict of interest has now been answered. |
Hi Wikipedia - I am opening another edit request in hopes of having a few minor updates made to the lede and infobox of this article. My last request was declined, however as requested I have gathered some additional third-party citations to support the edits. My request and citations are as follows:
- After the first sentence in the lede, can we add "ApiJect works with pharmaceutical and biotech companies to fill their injectable drug products into single-dose prefilled injectors" (Sources: https://drug-dev.com/special-feature-pfs-parenteral-drug-delivery-self-injection-is-very-much-the-new-normal/ and https://homelandprepnews.com/stories/76769-aspr-celebrates-construction-of-new-research-and-development-facility-for-production-of-prefilled-injectors/)
- Infobox updates: Remove Franco Negron, and add CEO to Jay Walker’s title. The source is https://www.drugdeliverybusiness.com/apiject-picks-up-111m-investment-from-royalty-pharma-jefferies/
Thanks in advance for any help here! - Ewapi (talk) 19:04, 13 June 2022 (UTC)
- Hi Ewapi, apologies for missing your tag in the last request. Thanks for gathering new citations - these edits are Done. - Cmccarthy215 (talk) 16:27, 27 June 2022 (UTC)